FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

NEWSROOM CLOSED FOR THE HOLIDAYS

[ Price : $8.95]

FDA Webview closes its newsroom for the end-of-year Holiday Season, reopening Monday, Jan 5, 2026.

FDA Flags Sterility/Quality Control at SCA Pharma

[ Price : $8.95]

FDA cites SCA Pharmaceuticals for multiple deficiencies in sterile drug manufacturing practices following a 10-day inspection of t...

Cobenfy TV Spot False or Misleading: FDA

[ Price : $8.95]

The CDER Office of Prescription Drug Promotion says a TV spot for Karuna Therapeutics Cobenfy is false or misleading in its descri...

UBI FDA-483 Has 5 Observations

[ Price : $8.95]

FDA releases the form FDA-483 with five observations from a recent inspection of the UBI Pharma drug manufacturing facility in Hsi...

Lillys Oral GLP-1 Maintains Weight Loss After Switch

[ Price : $8.95]

A new study shows that Eli Lillys investigational oral obesity drug helped patients largely maintain weight loss after transitioni...

Novo Nordisk Files CagriSema NDA for Weight Loss

[ Price : $8.95]

Novo Nordisk says it expects FDA to review in 2026 the companys NDA for CagriSema, an injectable once-weekly weight loss treatment...

FDA Sends Warning Letters to Makers of Breast Binders

[ Price : $8.95]

FDA begins enforcement actions against companies illegally marketing breast binders to children, placing the agencys role at the c...

PDUFA Talks Hit Snag on Review Timelines/Transparency

[ Price : $8.95]

During recent drug user fee negotiations on reauthorizing the PDUFA program, FDA officials and pharmaceutical industry representat...

FDA OKs Subcutaneous Version of J&J Lung Cancer Drug

[ Price : $8.95]

FDA approves a new subcutaneous formulation of Johnson & Johnsons lung cancer drug amivantamab, allowing the therapy to be adminis...

Clinical Hold on Lung Cancer Trial After Deaths

[ Price : $8.95]

Regulators place a clinical hold on a pivotal lung cancer trial of ifinatamab deruxtecan after reports of treatment-related deaths...